Denosumab biosimilar is under clinical development by Samsung Bioepis and currently in Phase III for Post Menopausal Osteoporosis.

The purpose of this review is to describe the available evidence for osteoporosis treatments in young and premenopausal women. A review of articles evaluating the treatment or prevention of ...

Osteoporosis affects both men and women, but women face higher risks due to biological differences, menopause, and pregnancy.

Osteoporosis, characterized by an imbalance in bone remodeling, is a growing health concern worldwide. Previous research has ...

Clinical practice guidelines (CPGs) are essential for guiding rehabilitation interventions. However, CPGs specifically addressing rehabilitation for osteoporosis patients remain scarce in the ...

Osteoporosis, characterized by an imbalance in bone remodeling, is a growing health concern worldwide. Previous research has ...

Osteoporosis, often described as a "silent disease," is characterized by weakened and brittle bones that become increasingly prone to fractures. This condition ...

But while the pair are used to competing at the highest level despite their disabilities, for Debra Sales-Tiffin, from Essex, ...

Researchers explored the association between osteoporosis and patient-reported outcomes among postmenopausal women with systemic sclerosis.

Osteoporosis is one of the common bone diseases resulted due to loss in bone mass. This disease starts developing when the body consumes more bone tissue than it produces; thus, this reduces the bone ...

Frailty is shown to be associated with lower bone mineral density (BMD) in the total hip among a predominantly male cohort of veterans with rheumatoid arthritis (RA), according to study results ...